BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21354544)

  • 1. [Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
    Cervigón I; Palomo A; Torres-Iglesias LM; Solano F; Zapata AM
    Actas Dermosifiliogr; 2011 May; 102(4):305-7. PubMed ID: 21354544
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal failure secondary to leukemic infiltration of kidneys in CLL--a case report and review of literature.
    Uprety D; Peterson A; Shah BK
    Ann Hematol; 2013 Jan; 92(2):271-3. PubMed ID: 22875063
    [No Abstract]   [Full Text] [Related]  

  • 3. [Renal infiltrate by a plasmocytoïd chronic B lymphocytic leukaemia and renal failure: a rare occurrence in nephropathology. A case report and review of the literature].
    Aymard B; Beghoura R; Molina TJ
    Nephrol Ther; 2011 Nov; 7(6):479-87. PubMed ID: 21439927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lymphocytic leukemia masquerading as uveitis.
    Gupta G; Larson RA; Jampol LM
    Retina; 2007; 27(9):1311-2. PubMed ID: 18046244
    [No Abstract]   [Full Text] [Related]  

  • 6. Changing the way we think about chronic lymphocytic leukemia.
    Lin TS; Grever MR; Byrd JC
    J Clin Oncol; 2005 Jun; 23(18):4009-12. PubMed ID: 15767640
    [No Abstract]   [Full Text] [Related]  

  • 7. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
    Ahmadi T; Schuster SJ
    J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
    [No Abstract]   [Full Text] [Related]  

  • 8. Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia.
    Schierl M; Foedinger D; Geissler K; Rappersberger K; Feldmann R
    Eur J Dermatol; 2008; 18(6):717-8. PubMed ID: 19049939
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia.
    Hillmen P; Cohen DR; Cocks K; Pettitt A; Sayala HA; Rawstron AC; Kennedy DB; Fegan C; Milligan DW; Radford J; Mercieca J; Dearden C; Ezekwisili R; Smith AF; Brown J; Booth GA; Varghese AM; Pocock C;
    Br J Haematol; 2011 Mar; 152(5):570-8. PubMed ID: 21231927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontline therapy for chronic lymphocytic leukemia: the dilemma continues.
    Nabhan C
    Clin Cancer Res; 2008 Jul; 14(13):4353. PubMed ID: 18594019
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical challenges in chronic lymphocytic leukemia.
    O'Brien S
    Semin Hematol; 1998 Jul; 35(3 Suppl 3):22-6. PubMed ID: 9685176
    [No Abstract]   [Full Text] [Related]  

  • 12. Asymptomatic cauliflower ears in a 73-year-old man. Diagnosis: Leukemia cutis in the setting of indolent B-cell chronic lymphocytic leukemia (B-CLL).
    Kim PS; Sheth PB
    Arch Dermatol; 2011 Dec; 147(12):1443, 1448. PubMed ID: 22184770
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab.
    Smolej L; Belada D; Cermanová M; Maisnar V; Lunáková E
    Leuk Res; 2010 May; 34(5):e140-1. PubMed ID: 20053448
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal dysfunction due to leukemic infiltration of kidneys in a case of chronic lymphocytic leukemia.
    Ferreira AC; Brum S; Carvalho D; Pataca I; Carvalho F; Santos MC; Santos JR
    Hemodial Int; 2010 Jan; 14(1):87-90. PubMed ID: 19758305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
    Antich Rojas J; Balaguer H; Cladera A
    Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment options for newly diagnosed patients with chronic lymphocytic leukemia.
    Erba HP
    Curr Hematol Rep; 2004 Jan; 3(1):47-53. PubMed ID: 14695850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxicodermia by bendamustine: development of a desensization protocol].
    Sangrador Pelluz C; Luis Hidalgo MM; Martínez García M; Pérez-Serrano Lainosa MD; Soler Company E
    Farm Hosp; 2013; 37(5):421-3. PubMed ID: 24128107
    [No Abstract]   [Full Text] [Related]  

  • 18. Refractory pure red-cell aplasia associated with B chronic lymphocytic leukemia successfully treated by fludarabine.
    Sandra S; Real E; Pastor E; Grau E
    Haematologica; 1999 Dec; 84(12):1154-5. PubMed ID: 10586218
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
    Herold T; Seiler T; Egensperger R; Trumm C; Bergmann M; Franke D; Mumm FF; Schinwald N; Buske C; Dreyling M
    Leuk Lymphoma; 2012 Jan; 53(1):169-72. PubMed ID: 21812535
    [No Abstract]   [Full Text] [Related]  

  • 20. Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
    Bosch F; Ferrer A; Villamor N; González M; Briones J; González-Barca E; Abella E; Gardella S; Escoda L; Pérez-Ceballos E; Asensi A; Sayas MJ; Font L; Altés A; Muntañola A; Bertazzoni P; Rozman M; Aymerich M; Giné E; Montserrat E
    Clin Cancer Res; 2008 Jan; 14(1):155-61. PubMed ID: 18172266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.